← Home / Cue Biopharma, Inc. (CUE)
Stock Analysis
Cue Biopharma, Inc. (CUE)
CUE
CUE · Market data
26.84 -11.71%
Track CUE in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when CUE price is:
52W Range Position
68%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-02 19:57 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 28.31. Holding above 21.83 keeps the current thesis intact.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
21.83
↗
Break Above
Confirmation improves above resistance.
28.31
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 21.83
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
10
↗
Equity Offering / Capital Raise
HIGH
CUE equity financing update
On July 9, 2026, Cue Biopharma, Inc.
8-K Filing • SEC EDGAR
JUL
10
●
Management / Board
HIGH
Cue Biopharma Announces $50.0 Million Private Placement
(Nasdaq: CUE), a clinical stage biopharmaceutical company focused on developing transformative therapies targeting functional cures for immunological disorders, today announced that it has entered into a securities purchase agreement with a group of accredited investors for the private placement of (i) 1,418,071 sha...
8-K Filing • SEC EDGAR
JUN
3
●
Management / Board
MEDIUM
CUE board and management update
(the “Company”) held on June 1, 2026 (the “Special Meeting”), the Company’s stockholders approved the Cue Biopharma, Inc.
8-K Filing • SEC EDGAR
What's Driving CUE?
📈 Technical recovery is improving
Momentum is Neutral. Watch 28.31 for confirmation and 21.83 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 21.83
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
43.2
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 21.83 and resistance at 28.31. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
CUE — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$87.4M
Company size
EV
$72.1M
Debt-adjusted value
P/E
-4.5
Not meaningful
P/S
2.7
Low sales multiple
P/B
4.0
Balanced
EV/Sales
2.2
Low sales multiple
EV/EBIT
-3.7
Not meaningful
P/FCF
-3.6
Not meaningful
FCF Yield
-28.16%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
5.69M
↗ Strong
📈 Net Income
-5.18M
↘ Negative
🧮 EPS (Basic)
-1.08
↘ Negative
Cue Biopharma, Inc.
Related Opportunities